Table 8.
Synthetic view of the associations identified between soluble markers of B cell activation and clinical markers of PH in the discovery and validation cohorts.
Discovery cohort | Validation cohort | ||
---|---|---|---|
PH vs no PH |
IgG
RF |
PAH vs no PAH |
IgG
β2-microglobulin sBCMA sCD23 sCD27 |
Nt-pro-BNP |
β2-microglobulin
sBCMA |
Nt-pro-BNP | BAFF |
Peak TRV |
BAFF
RF |
Peak TRV | BAFF IgM |
DLCO |
β2-microglobulin
BAFF sCD23 RF |
FVC/DLCO | β2-microglobulin BAFF IgG |
BAFF, B-cell-activating factor; BCMA, B-cell maturation antigen; CD, cluster of differentiation; DLCO, diffusing capacity of the lung for carbon monoxide; Nt-pro-BNP, N-terminal prohormone of brain natriuretic peptide; PAH, pulmonary arterial hypertension; PH, pulmonary hypertension; RF, rheumatoid factor; s, soluble; TRV, tricuspid regurgitation velocity.
Bold characters denote statistical significance (p< 0.05). Regular characters denote trends for statistical significance (p< 0.10).